Literature DB >> 12746114

Main vascular changes seen in the saline controls of continuous infusion studies in the cynomolgus monkey over an eight-year period.

Juliette Lilbert1, Roger Burnett.   

Abstract

The aim of this study was to characterize the main vascular lesions seen in the saline controls in continuous infusion studies in monkeys. Data were collected from 17 studies over an 8-year period (ie, around 50 males and 50 females). The study was restricted to lesions at the injection site, in lungs and at the entry point. It showed that the level of the most severe procedure-related lesions (ie, necrosis with abscess formation at the injection site and at the entry point, thromboemboli and probable infarcts in lungs) was low (<10%). Minor changes such as endothelial hyperplasia and intimal thickening at the injection site, and low-graded interstitial pneumonitis in lungs were the most frequent changes (40 to 50% of the animals). Thrombi at the injection site were present in around 30% in males and 40% in females. The slightly higher incidence of thrombi in females was not explained by a difference of vessel size or by hematological differences. This study permitted an opportunity to harmonise terminology among pathologists and to define the main procedure-related changes and their incidence, which could help pathologists better interpret changes in future infusion studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746114     DOI: 10.1080/01926230390204306

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  4 in total

1.  Cranial Vena Cava Syndrome in Guinea Pigs with Chronic Jugular Vein Catheters.

Authors:  Timothy K Cooper; Russell A Byrum; Kurt Cooper; Lisa Evans DeWald; Nina M Aiosa; Irwin M Feuerstein; Marisa C St Claire
Journal:  Comp Med       Date:  2020-01-16       Impact factor: 0.982

2.  Pathology in Continuous Infusion Studies in Rodents and Non-Rodents and ITO (Infusion Technology Organisation)-Recommended Protocol for Tissue Sampling and Terminology for Procedure-Related Lesions.

Authors:  Klaus Weber; Vasanthi Mowat; Elke Hartmann; Tanja Razinger; Hans-Jörg Chevalier; Kai Blumbach; Owen P Green; Stefan Kaiser; Stephen Corney; Ailsa Jackson; Agustin Casadesus
Journal:  J Toxicol Pathol       Date:  2011-06-30       Impact factor: 1.628

3.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

4.  CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.

Authors:  Anthony Shock; Linda Burkly; Ian Wakefield; Christopher Peters; Ellen Garber; Janine Ferrant; Frederick R Taylor; Lihe Su; Yen-Ming Hsu; David Hutto; Ali Amirkhosravi; Todd Meyer; John Francis; Sarah Malcolm; Martyn Robinson; Derek Brown; Stevan Shaw; Roland Foulkes; Alastair Lawson; Olivier Harari; Timothy Bourne; Alison Maloney; Neil Weir
Journal:  Arthritis Res Ther       Date:  2015-09-03       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.